Editorial Board
Rob van den Brom
University Medical Center Groningen · Netherlands
Editorial leadership for Journal of Neoplasms ISSN 2639-1716
Research interests
- Melanoma Renal Cell Carcinoma Gist Immune Checkpoint Inhibitors
Biography
Publications:
- Systemic vasculitis developed after immune checkpoint inhibition.
- Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition.
- Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.
- Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma.
- Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).
- Effect of vemurafenib on a V600R melanoma brain metastasis.
- Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
- Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer.
Considering JN for your work?
This journal is guided by Rob van den Brom (University Medical Center Groningen) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.